New epilepsy drug candidate iQ-007 enters first human safety trial
Knowledge-focused
Ongoing
This early-stage trial tests the safety of an experimental oral drug called iQ-007 in 72 healthy volunteers. The drug is designed to help control seizures by boosting the brain's ability to clear excess glutamate, a chemical linked to epilepsy. The study does not yet test if it w…
Phase: PHASE1 • Sponsor: iQure Australia Pty Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC